Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Tolbutamide

Severity: Minor

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Tolbutamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elvitegravir may induce CYP2C9, which could lower tolbutamide concentrations, while cobicistat inhibits other CYPs. The net effect on glycemic control is uncertain, and reduced tolbutamide efficacy is possible.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Tolbutamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible CYP2C9 induction by elvitegravir increasing tolbutamide clearance.

What to do

Monitor blood glucose after starting or stopping the regimen. Increase the tolbutamide dose if control worsens.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Tolbutamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Tolbutamide?

MediHelp rates the interaction as minor. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Tolbutamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elvitegravir may induce CYP2C9, which could lower tolbutamide concentrations, while cobicistat inhibits other CYPs. The net effect on glycemic control is uncertain, and reduced tolbutamide efficacy is possible.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Tolbutamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting or stopping the regimen. Increase the tolbutamide dose if control worsens.

What other medicines interact with Tolbutamide?

MediHelp also lists interactions of Tolbutamide with, for example, Glyburide-metformin, Insulin degludec-liraglutide, Aceclofenac. The full list is on the Tolbutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in